XML 88 R47.htm IDEA: XBRL DOCUMENT v3.20.2

Goodwill and in Process Research and Development (Brooklyn ImmunoTherapeutics, LLC) (10-K)	12 Months Ended
	Dec. 31, 2019
Brooklyn Immunotherapeutics, LLC [Member]
Goodwill and In Process Research and Development	NOTE 6 GOODWILL AND IN PROCESS RESEARCH AND DEVELOPMENT The Company recorded Goodwill and IPR&D in the amount of $2,043,747 and $6,860,000, respectively, in connection with the Business Combination (see Note 4 – Business Combination). IPR&D assets are considered to be indefinite-lived until the completion or abandonment of the associated research and development projects.

X

- Definition

Goodwill and in process research and development [Text Block].

+ References

No definition available.

+ Details

Name:	NTN_GoodwillAndInProcessResearchAndDevelopmentTextBlock
Namespace Prefix:	NTN_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_ConsolidatedEntitiesAxis=NTN_BrooklynImmunotherpeuticsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: